TYRA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.40%

Insider Buying (Last 12 Months): $152,000.00

Insider Selling (Last 12 Months): $2,607,696.59

Tyra Biosciences Insider Trading History Chart

Tyra Biosciences Share Price & Price History

^$16.18

▲ +0.35 (2.21%)

As of 11/25/2024 01:00 AM ET

Days: 30 | 90 | 365

The Biggest Post-Election Market Shift Ever?

From Stansberry Research | Ad

Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.

Get our No. 1 stock (with 500%-plus upside potential) for this rare market event now.

Tyra Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/4/2024	Nina S Kjellson	Director	Sell	1,076	$17.01	$18,302.76	458,390
11/1/2024	Nina S Kjellson	Director	Sell	27,493	$16.56	$455,284.08	458,506
10/30/2024	Alan Fuhrman	CFO	Buy	9,500	$16.00	$152,000.00	12,849
10/30/2024	Nina S Kjellson	Director	Sell	11,078	$16.17	$179,131.26	472,207
10/21/2024	Todd Harris	CEO	Sell	19,084	$27.90	$532,443.60	1,355,927
10/17/2024	Todd Harris	CEO	Sell	15,394	$25.85	$397,934.90	1,418,647
10/15/2024	Todd Harris	CEO	Sell	10,035	$24.31	$243,950.85	1,467,338
9/30/2024	Todd Harris	CEO	Sell	500	$24.00	$12,000.00	1,477,373
9/25/2024	Todd Harris	CEO	Sell	600	$24.01	$14,406.00	1,477,873
9/23/2024	Todd Harris	CEO	Sell	10,092	$24.13	$243,519.96	1,479,528
9/19/2024	Todd Harris	CEO	Sell	5,698	$24.31	$138,518.38	1,496,729
6/10/2024	Daniel Bensen	COO	Sell	3,502	$20.00	$70,040.00	427,981
6/7/2024	Daniel Bensen	COO	Sell	200	$20.00	$4,000.00	431,483
3/11/2024	Daniel Bensen	COO	Sell	200	$20.00	$4,000.00	431,683
3/6/2024	Daniel Bensen	COO	Sell	1,733	$20.09	$34,815.97	431,951
2/29/2024	Daniel Bensen	COO	Sell	2,050	$20.00	$41,000.00	442,836
2/27/2024	Daniel Bensen	COO	Sell	745	$20.00	$14,900.00	450,735
2/12/2024	Daniel Bensen	COO	Sell	1,501	$20.00	$30,020.00	451,480
2/7/2024	Daniel Bensen	COO	Sell	9,587	$18.09	$173,428.83	452,981
7/21/2023	Daniel Bensen	COO	Sell	3,900	$16.01	$62,439.00	527,981
7/19/2023	Daniel Bensen	COO	Sell	207	$16.07	$3,326.49	527,981
7/17/2023	Daniel Bensen	COO	Sell	1,900	$16.03	$30,457.00	527,981
7/13/2023	Daniel Bensen	COO	Sell	500	$16.13	$8,065.00	527,981
7/11/2023	Daniel Bensen	COO	Sell	500	$16.02	$8,010.00	527,981
7/3/2023	Daniel Bensen	COO	Sell	4,265	$16.37	$69,818.05	527,981
6/30/2023	Daniel Bensen	COO	Sell	18,819	$16.97	$319,358.43	527,981
6/27/2023	Daniel Bensen	COO	Sell	16,028	$16.91	$271,033.48	527,981
6/22/2023	Todd Harris	CEO	Sell	3,478	$17.04	$59,265.12	1,621,988
6/20/2023	Todd Harris	CEO	Sell	1,300	$16.53	$21,489.00	1,645,222
6/15/2023	Todd Harris	CEO	Sell	12,773	$16.13	$206,028.49	1,701,276
6/14/2023	Daniel Bensen	COO	Sell	120	$16.45	$1,974.00	527,981
6/13/2023	Todd Harris	CEO	Sell	7,927	$16.00	$126,832.00	1,701,276
4/3/2023	Daniel Bensen	COO	Sell	2,000	$16.16	$32,320.00	527,981
3/31/2023	Daniel Bensen	COO	Sell	400	$16.00	$6,400.00	527,981
3/30/2023	Todd Harris	CEO	Sell	2,407	$16.02	$38,560.14	1,701,276
3/29/2023	Daniel Bensen	COO	Sell	2,187	$16.21	$35,451.27	527,981
3/28/2023	Todd Harris	CEO	Sell	2,779	$16.00	$44,464.00	1,701,276
3/27/2023	Daniel Bensen	COO	Sell	8,048	$16.00	$128,768.00	527,981
3/24/2023	Todd Harris	CEO	Sell	170	$16.00	$2,720.00	1,701,276
3/22/2023	Daniel Bensen	COO	Sell	3,800	$16.00	$60,800.00	527,981
3/22/2023	Todd Harris	CEO	Sell	4,043	$16.00	$64,688.00	1,701,276
2/9/2023	Mva Investors, Llc	Major Shareholder	Sell	200,000	$13.10	$2,620,000.00	88,095
12/17/2021	Boxer Capital, Llc	Major Shareholder	Buy	125,000	$13.12	$1,640,000.00

DeFi Coin on Verge of Breakout!

From Crypto 101 Media | Ad

The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.

Claim your FREE book now before it's too late!

SEC Filings (Institutional Ownership Changes) for Tyra Biosciences (NASDAQ:TYRA)

84.14% of Tyra Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Tyra Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	37,625	$0.88M	0.0%	+200.5%	0.074%
11/15/2024	Frazier Life Sciences Management L.P.	731,020	$17.19M	0.7%	-12.2%	1.445%
11/15/2024	Barclays PLC	37,625	$0.88M	0.0%	+200.5%	0.074%
11/15/2024	Wellington Management Group LLP	90,825	$2.14M	0.0%	-22.4%	0.179%
11/15/2024	State Street Corp	384,732	$9.05M	0.0%	+4.4%	0.760%
11/15/2024	Polar Asset Management Partners Inc.	88,100	$2.07M	0.0%	N/A	0.174%
11/15/2024	Janus Henderson Group PLC	1,067,196	$24.99M	0.0%	N/A	2.109%
11/15/2024	Cinctive Capital Management LP	22,900	$0.54M	0.0%	N/A	0.045%
11/14/2024	Sio Capital Management LLC	400,870	$9.42M	3.7%	-33.2%	0.792%
11/14/2024	Walleye Capital LLC	126,597	$2.98M	0.0%	+306.5%	0.250%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	25,209	$0.59M	0.0%	N/A	0.050%
11/14/2024	Ally Bridge Group NY LLC	270,075	$6.35M	3.4%	+2.0%	0.534%
11/13/2024	FMR LLC	3,372,850	$79.30M	0.0%	+0.8%	6.666%
11/13/2024	The Manufacturers Life Insurance Company	14,184	$0.33M	0.0%	N/A	0.028%
11/12/2024	Valence8 US LP	13,188	$0.31M	0.1%	N/A	0.025%
11/12/2024	Charles Schwab Investment Management Inc.	173,737	$4.09M	0.0%	+2.2%	0.329%
11/8/2024	Jennison Associates LLC	158,187	$3.72M	0.0%	+5.9%	0.300%
11/7/2024	Quest Partners LLC	20,878	$0.49M	0.0%	N/A	0.040%
11/6/2024	Oppenheimer & Co. Inc.	76,806	$1.81M	0.0%	+9.0%	0.145%
11/5/2024	Victory Capital Management Inc.	30,080	$0.71M	0.0%	-36.2%	0.057%
10/30/2024	Auour Investments LLC	21,020	$0.49M	0.2%	-75.3%	0.040%
10/10/2024	Exchange Traded Concepts LLC	8,311	$0.20M	0.0%	-32.1%	0.016%
10/3/2024	SG Americas Securities LLC	13,211	$0.31M	0.0%	N/A	0.025%
8/16/2024	Perceptive Advisors LLC	1,007,367	$16.11M	0.4%	+50.5%	1.908%
8/14/2024	Ally Bridge Group NY LLC	264,660	$4.23M	2.5%	N/A	0.501%
8/14/2024	HighVista Strategies LLC	16,078	$0.26M	0.1%	N/A	0.030%
8/13/2024	Ensign Peak Advisors Inc	190,557	$3.05M	0.0%	N/A	0.361%
8/8/2024	American Century Companies Inc.	170,283	$2.72M	0.0%	+582.9%	0.324%
8/5/2024	Victory Capital Management Inc.	47,160	$0.75M	0.0%	-1.9%	0.090%
8/1/2024	Rhumbline Advisers	23,572	$0.38M	0.0%	+12.3%	0.045%
7/26/2024	Bank of New York Mellon Corp	58,087	$0.93M	0.0%	+32.8%	0.111%
5/17/2024	RA Capital Management L.P.	10,416,609	$170.83M	2.2%	+43.9%	19.826%
5/16/2024	Kynam Capital Management LP	515,190	$8.45M	0.9%	+51.4%	0.981%
5/16/2024	BVF Inc. IL	4,661,194	$76.44M	2.1%	+70.1%	8.872%
5/10/2024	Vanguard Group Inc.	899,800	$14.76M	0.0%	+18.6%	1.713%
5/7/2024	Oppenheimer & Co. Inc.	59,576	$0.98M	0.0%	N/A	0.113%
4/23/2024	Fishman Jay A Ltd. MI	15,000	$0.25M	0.0%	N/A	0.029%
3/5/2024	Wellington Management Group LLP	102,436	$1.42M	0.0%	+8.8%	0.238%
2/15/2024	Frazier Life Sciences Management L.P.	1,026,420	$14.22M	0.8%	-0.2%	2.384%
2/14/2024	Artia Global Partners LP	10,253	$0.14M	0.0%	-77.3%	0.024%
2/14/2024	Kynam Capital Management LP	340,190	$4.71M	0.5%	N/A	0.790%
2/6/2024	AJOVista LLC	4,235	$59K	0.1%	N/A	0.010%
2/5/2024	Victory Capital Management Inc.	50,220	$0.70M	0.0%	+53.4%	0.117%
1/31/2024	Federated Hermes Inc.	2,070	$29K	0.0%	+1,244.2%	0.005%
1/5/2024	Exchange Traded Concepts LLC	9,531	$0.13M	0.0%	+34.0%	0.022%
12/1/2023	Wellington Management Group LLP	94,112	$1.30M	0.0%	+18.5%	0.219%
11/14/2023	Corton Capital Inc.	11,009	$0.15M	0.1%	N/A	0.026%
11/13/2023	FMR LLC	3,898,827	$53.69M	0.0%	-5.3%	9.054%
11/1/2023	Simplex Trading LLC	2,009	$27K	0.0%	+198.1%	0.005%
10/24/2023	Bank of New York Mellon Corp	41,870	$0.58M	0.0%	+2.6%	0.097%
10/18/2023	Exchange Traded Concepts LLC	7,114	$98K	0.0%	-19.8%	0.017%
9/21/2023	Barclays PLC	2,788	$48K	0.0%	-58.9%	0.006%
8/24/2023	Perceptive Advisors LLC	360,000	$6.13M	0.2%	-27.2%	0.837%
8/15/2023	BVF Inc. IL	2,739,595	$46.66M	1.3%	-15.4%	6.370%
8/14/2023	Driehaus Capital Management LLC	150,468	$2.56M	0.0%	+12.1%	0.350%
7/24/2023	Allspring Global Investments Holdings LLC	2,273	$39K	0.0%	N/A	0.005%
7/20/2023	Exchange Traded Concepts LLC	8,867	$0.15M	0.0%	N/A	0.021%
7/18/2023	Allspring Global Investments Holdings LLC	2,273	$39K	0.0%	N/A	0.005%
7/7/2023	Auour Investments LLC	85,020	$1.45M	0.6%	N/A	0.200%
5/16/2023	BVF Inc. IL	3,239,595	$52.06M	1.9%	+31.0%	7.611%
5/15/2023	Logos Global Management LP	87,673	$1.41M	0.2%	-20.9%	0.206%
5/11/2023	FMR LLC	3,147,987	$50.59M	0.0%	-18.8%	7.397%
5/2/2023	Victory Capital Management Inc.	33,760	$0.54M	0.0%	N/A	0.079%
11/15/2022	TCG Crossover Management LLC	945,707	$8.31M	2.5%	+5.5%	2.241%
11/15/2022	Logos Global Management LP	127,316	$1.12M	0.1%	-23.5%	0.302%
10/28/2022	Sepio Capital LP	10,625	$93K	0.0%	N/A	0.025%
10/26/2022	Fishman Jay A Ltd. MI	10,500	$92K	0.0%	N/A	0.025%
8/16/2022	Woodline Partners LP	289,172	$2.07M	0.0%	+8.6%	0.692%
8/15/2022	Sio Capital Management LLC	152,159	$1.09M	0.4%	+37.0%	0.364%
8/10/2022	Frazier Life Sciences Management L.P.	1,375,065	$9.83M	0.9%	+3.6%	3.293%
7/27/2022	Bailard Inc.	12,910	$92K	0.0%	N/A	0.031%
5/17/2022	Fairmount Funds Management LLC	1,284,990	$13.75M	3.3%	+99.1%	3.077%
5/16/2022	Frazier Life Sciences Management L.P.	1,327,665	$14.21M	1.2%	N/A	3.179%
5/5/2022	New York State Common Retirement Fund	10,517	$0.11M	0.0%	N/A	0.025%
2/19/2022	Woodline Partners LP	264,745	$3.73M	0.1%	-27.7%	0.642%
2/18/2022	TCG Crossover Management LLC	850,450	$11.97M	5.6%	N/A	2.061%
2/14/2022	Boxer Capital LLC	6,448,359	$90.73M	3.5%	+2.0%	15.626%
2/14/2022	Perceptive Advisors LLC	673,352	$9.47M	0.1%	-31.8%	1.632%
2/14/2022	Nextech Invest AG	2,518,582	$35.44M	8.2%	N/A	6.103%
2/8/2022	Northern Trust Corp	103,493	$1.46M	0.0%	N/A	0.251%
2/3/2022	Canaan Partners XI LLC	4,409,991	$62.05M	16.0%	N/A	10.687%
1/24/2022	Strs Ohio	2,800	$39K	0.0%	N/A	0.007%
12/3/2021	Perceptive Advisors LLC	987,500	$17.37M	0.2%	N/A	2.393%
11/16/2021	Janus Henderson Group PLC	1,374,648	$22.84M	0.0%	N/A	3.331%
11/16/2021	Wellington Management Group LLP	695,371	$12.23M	0.0%	N/A	1.685%
11/16/2021	BVF Inc. IL	1,694,933	$29.81M	1.2%	N/A	4.107%
11/16/2021	Boxer Capital LLC	6,323,359	$111.23M	3.9%	N/A	15.323%
11/15/2021	Deerfield Management Company L.P. Series C	625,000	$10.99M	0.2%	N/A	1.515%
11/15/2021	RA Capital Management L.P.	7,236,454	$127.29M	1.8%	N/A	17.536%
11/15/2021	Ensign Peak Advisors Inc	125,000	$2.20M	0.0%	N/A	0.303%
11/10/2021	Goldman Sachs Group Inc.	207,283	$3.65M	0.0%	N/A	0.502%
11/9/2021	Jennison Associates LLC	468,750	$8.25M	0.0%	N/A	1.136%

Data available starting January 2016

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

Today's Range

Now: $16.18

$16.05

$17.02

50 Day Range

MA: $20.78

$15.36

$28.61

52 Week Range

Now: $16.18

$10.60

$29.60

Volume

293,621 shs

Average Volume

194,612 shs

Market Capitalization

$818.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08

Who are the company insiders with the largest holdings of Tyra Biosciences?: Tyra Biosciences' top insider investors include:
Todd Harris (CEO)
Daniel Bensen (COO)
Nina S Kjellson (Director)
Mva Investors, Llc (Major Shareholder)
Alan Fuhrman (CFO)
Learn More about top insider investors at Tyra Biosciences.
Who are the major institutional investors of Tyra Biosciences?: Tyra Biosciences' top institutional investors include:
FMR LLC — 6.67%
Janus Henderson Group PLC — 2.11%
Frazier Life Sciences Management L.P. — 1.44%
Sio Capital Management LLC — 0.79%
State Street Corp — 0.76%
Ally Bridge Group NY LLC — 0.53%
Learn More about top institutional investors of Tyra Biosciences stock.
Which institutional investors are selling Tyra Biosciences stock?: Within the last quarter, TYRA stock was sold by these institutional investors:
Sio Capital Management LLC
Frazier Life Sciences Management L.P.
Auour Investments LLC
Wellington Management Group LLP
Victory Capital Management Inc.
Exchange Traded Concepts LLC
In the last year, company insiders that have sold Tyra Biosciences company stock include:
Todd Harris (CEO)
Daniel Bensen (COO)
Nina S Kjellson (Director)
Learn More investors selling Tyra Biosciences stock.
Which institutional investors are buying Tyra Biosciences stock?: In the last quarter, TYRA stock was purchased by institutional investors including:
Janus Henderson Group PLC
Walleye Capital LLC
Polar Asset Management Partners Inc.
FMR LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Barclays PLC
Barclays PLC
Cinctive Capital Management LP